A national precision cancer medicine implementation initiative for Norway
Nat Med
.
2022 May;28(5):885-887.
doi: 10.1038/s41591-022-01777-4.
Authors
Kjetil Taskén
1
2
,
Hege E G Russnes
3
4
5
,
Eline Aas
6
7
,
Line Bjørge
8
9
10
,
Egil S Blix
11
12
;
CONNECT Public–Private Partnership Consortium
;
Espen Enerly
13
,
Gro L Fagereng
14
,
Åsmund Flobak
15
16
,
Bjørnar Gilje
17
,
Bjørn T Gjertsen
9
10
18
,
Tormod K Guren
19
,
Jutta Heix
20
,
Eivind Hovig
21
22
,
Randi Hovland
23
;
InPreD-Norway and National Molecular Tumor Board Consortium
;
IMPRESS-Norway Consortium
;
Per E Lønning
10
24
,
Leonardo A Meza-Zepeda
21
25
,
Per M Mæhle
26
,
Hilde L Nilsen
3
27
,
Steinar Ø Thoresen
20
28
,
Ketil Widerberg
20
,
Sigbjørn Smeland
3
26
,
Åslaug Helland
3
5
19
Collaborators
Terje C Ahlquist
,
Nyosha Alikhani
,
Ali Areffard
,
Eli Bergli
,
Hege Edvardsen
,
Gry Festervoll
,
Grethe S Foss
,
Petter Foss
,
Ingvild Hagen
,
Kåre B Hagen
,
Håvard H Hauge
,
Bjorn V Herikstad
,
Kristian Hveem
,
Elisabeth Jarnaess
,
Kristin Kittelsen
,
Kristin Krogsrud
,
Monica Larsen
,
Mariam Lofwander
,
Birgitte Lygren
,
Aslaug Muggerud
,
Cathrine S Notland
,
Ole A Oppdalshei
,
Ravinder Singh
,
Svein Skeie
,
Fredrik Sund
,
Lars P Strand
,
Lidziya Ulvenes
,
Giske Ursin
,
Sverrir Valgardsson
,
Pål Wiik
,
Naoko Yamagata
,
Thomas Berg
,
Diana L Bordin
,
Hans-Rickard Brattbakk
,
Richard Doughty
,
Kari Ersland
,
Rakel Forthun
,
Einar Gudlaugsson
,
Hanne Hamre
,
Hans Kristian Haugland
,
Emiel Janssen
,
Mari Jebens
,
Tonje Lien
,
Susanne Lorenz
,
Torben Lüders
,
Pitt Niehusmann
,
John C Noone
,
Vigdis Nygaard
,
Ulla Randen
,
Anne Renolen
,
Anne J Skjulsvik
,
Sigmund V Sperstad
,
Olav K Vintermyr
,
Daniel Vodak
,
Teresia Wangensteen
,
Ragnhild M Wold
,
Kristin Åberg
,
Gro Live Fagereng
,
Khalid Al-Shibli
,
Yvonne Andersson
,
Egil Blix
,
Bodil Bjerkehagen
,
Sigmund Brabrand
,
Odd Terje Brustugun
,
Marte G Cameron
,
Astrid Dalhaug
,
Dalia Dietzel
,
Tom Dønnem
,
Ragnhild S Falk
,
Sverre Fluge
,
Bjørn H Grønberg
,
Kari Grønås
,
Hanne Hamre
,
Åse Haug
,
Daniel Heinrich
,
Geir Olav Hjortland
,
Gunnar Houge
,
Ann-Charlotte Iversen
,
Stian Knappskog
,
Jon Amund Kyte
,
Hedda von der Lippe Gythfeldt
,
Kristina Lindemann
,
Ragnhild A Lothe
,
Jo-Åsmund Lund
,
Per Eystein Lønning
,
Leonardo Meza-Zepeda
,
Monica C Munthe-Kaas
,
Olav T D Nguyen
,
Pitt Niehusmann
,
Katarina Puco
,
Anne H Ree
,
Tonje B Riste
,
Karin Semb
,
Eli Sihn S Steinskog
,
Andreas Stensvold
,
Pål Suhrke
,
Øyvind Tennøe
,
Geir E Tjønnfjord
,
Liv J Vassbotn
,
Sissel F Wahl
Affiliations
1
Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Kjetil.tasken@medisin.uio.no.
2
Institute of Clinical Medicine, University of Oslo, Oslo, Norway. Kjetil.tasken@medisin.uio.no.
3
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
4
Department of Pathology, Oslo University Hospital, Oslo, Norway.
5
Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
6
Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.
7
Division of Health Services, Norwegian Institute of Public Health, Oslo, Norway.
8
Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
9
Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.
10
Department of Clinical Science, University of Bergen, Bergen, Norway.
11
Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
12
Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.
13
Department of Research, Cancer Registry of Norway, Oslo, Norway.
14
Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
15
The Cancer Clinic, St. Olav University Hospital, Trondheim, Norway.
16
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
17
Department of Oncology, Stavanger University Hospital, Stavanger, Norway.
18
Haematology Section, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
19
Department of Oncology, Oslo University Hospital, Oslo, Norway.
20
CONNECT Public-Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway.
21
Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
22
Centre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway.
23
Section for Cancer Genomics, Haukeland University Hospital, Bergen, Norway.
24
Department of Oncology, Haukeland University Hospital, Bergen, Norway.
25
Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
26
Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
27
Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway.
28
Merck AB NUF, Oslo, Norway.
PMID:
35513529
DOI:
10.1038/s41591-022-01777-4
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Neoplasms* / genetics
Neoplasms* / therapy
Norway
Precision Medicine*